Historical considerations
=========================

In 1862 Edwin Smith, Egyptologist, acquired a papyrus that was thought to be between 2,500 and 3,000 years old. It was translated in 1930 by James Breasted, and was found to contain information on medical therapies performed on 48 patients, including six cases of cervical spine trauma. In the papyrus these injuries were described as \'dislocation of the vertebrae of the neck with unconscious arms and legs, where urine was drained and the phallus was erect, and it was determined that this cannot be treated\' \[[@B1]\].

Other physicians like Hippocrates and Claudius Galen made historical reference to the management of spinal cord injury. Galen studied injuries in gladiators, and described \'that injury of the spinal cord caused paralysis and loss of sensation below the level of injury \... and determined that high spinal cord injuries are incompatible with life\' \[[@B2],[@B3]\].

Chaulic Guy (1300 to 1360) carried out innovations in the management of traumatic bone injuries by introducing boards and suspensions to treat these fractures; however, he gave a pessimistic view on spinal injuries \[[@B4],[@B5]\].

Ambrose Pare (1510 to 1590) developed spine surgery, and along with Hildanus Fabricius (1560 to 1634) used traction techniques, reduction and utilization of wood frames to treat cervical spine fractures \[[@B6]\].

Louis Pasteur\'s (1822 to 1895) surgical innovations and discoveries and the advent of asepsis and antisepsis by Semmelweis (1816 to 1868) and others, and primarily the application of general anesthesia by Morton (1819 to 1868) and others gave a new impulse to this field. Together these developments helped reduce surgical mortality and infections \[[@B5],[@B7]\].

In the nineteenth century, anatomy and physiology of the central nervous system were studied. The neuron doctrine was developed by Santiago Ramon y Cajal (1852 to 1934), who demonstrated the individuality of nerve cells and the connections that they have with each other \[[@B8],[@B9]\].

Alfred R Allen between 1908 and 1911 developed a reproducible and quantifiable model that allowed induction of a uniform traumatic injury to the spine, and also explained the pathophysiological changes seen in spinal trauma, including key aspects of secondary spinal cord injury. In 1972 Tarlov showed that symptoms caused by compression of the spinal cord for more than 12 hours could sometimes still be reversed. During this period \'progressive central hemorrhagic necrosis\' was identified, which consists of bleeding from the gray matter of the spinal cord central necrosis and destruction of white matter, with subsequent cavitations \[[@B10],[@B11]\]. Finally, one of the possible immunomodalities of neuroprotection was suggested in 1968 by Albin and White who applied local hypothermia with favorable results in animals \[[@B12]\]. However, use of hypothermia was limited due to fear of side effects \[[@B13]-[@B17]\].

These preliminary studies were difficult to interpret due to the limited number of patients, lack of controls, concomitant surgical procedures and the concomitant use of drugs such as methylprednisolone \[[@B18]\]. In recent years there has been a renewed interest in the use of moderate therapeutic hypothermia due to its demonstrated neuroprotective effects in other areas. In Panama, we have been administering therapeutic hypothermia in selected cases with severe spinal cord injury. More frequently we apply fever management through endovascular, surface pads or medical thermomodulation protocols.

Epidemiological aspects of spinal cord injury
=============================================

No accurate numbers on spinal cord injury are available for Panama and Central America. In the United States there are around 12,000 new cases of traumatic spinal cord injury each year, not including those who die at the scene of the accident \[[@B19]\]. Approximately 1.3 million Americans have some type of chronic paralysis resulting from spinal cord injury \[[@B20],[@B21]\]. The leading causes are motor vehicle accidents (41.3%), falls (27.3%), acts of violence (15%) and recreational activities (7.9%). Apart from the medical and personal consequences for the patient, the economic impact in terms of ability to work is significant.

Spinal cord injury, neurophysiological aspects - how can therapeutic hypothermia help?
--------------------------------------------------------------------------------------

We will provide a concise description of the pathophysiological changes that occur after a spinal injury that might justify use of therapeutic hypothermia to mitigate ongoing destructive processes.

Spinal cord injury is a process that can be divided into three phases \[[@B22],[@B23]\]. The *primary mechanism*refers to the direct mechanical damage. This may include compression, stretching, persistent concussion, contusion, compression and laceration of the spinal cord \[[@B22],[@B23]\]. The *secondary mechanism*involves a cascade of events at the cellular level triggered by the primary mechanism. These biochemical events are responsible for increased tissue damage and promote the apoptotic cascade. These include those listed in Table [1](#T1){ref-type="table"}. The *healing mechanism*(third mechanism) begins in the days after injury and can last for months or years. This can paradoxically increase the neurological damage. Healing in the primary injury takes place by neutrophils, macrophages and lymphocytes, reactive astrocytes, Schwann cells, meningeal fibroblasts, and microglia invasion. Scar formation forms a barrier for cellular and molecular axonal regeneration.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1\. After the death of an oligodendrocyte, a progressive Walerian degeneration takes place from the site of primary injury, compromising the integrity of axons and mitochondria. Simultaneously caspase activation and apoptosis occur, leading finally to demyelination and release of nerve growth factor.
  2\. Vascular ischemia, impaired autoregulation, neurogenic shock, radial and axial hemorrhage, compromised microcirculation, collapsed veins, venous obstruction, vasospasm and thrombosis.
  3\. Ionic alterations: intracellular and extracellular calcium overload, increase of sodium and potassium.
  4\. Accumulation of neurotransmitters such as dopamine, norepinephrine, serotonin and glutamate at the extracellular level.
  5\. Release of arachidonic acid, production of free radicals and lipid eicosanoid peroxidation.
  6\. Endogenous opioid activation
  7\. Formation of cytotoxic and vasogenic edema
  8\. (Hyper)inflammatory response
  9\. Failure of ATP-dependent intracellular processes
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Therapeutic hypothermia has been used in various types of neurological injury such as stroke, post-anoxic encephalopathy, and traumatic brain injury. Some of these results have been extrapolated to spinal cord trauma patients.

Moderate therapeutic hypothermia has been shown to affect the apoptotic cascade as well as other destructive mechanisms, ranging from improved energy balance, reduction of mitochondrial dysfunction, decreased vascular permeability and capillary leakage, mitigation of cell membrane injury, improvement of intracellular acidosis, mitigation of DNA injury, reduction in metabolic demand, and a decrease in proinflammatory cytokine and free radical release \[[@B24]-[@B28]\].

It is important to realize that there is a window time, perhaps several hours to days after the injury, during which this treatment modality can influence the course of events \[[@B29]\].

Experimental studies and supporting evidence
============================================

Yu and colleagues used therapeutic hypothermia (33°C) after 30 minutes of ischemic injury to the thoracic spinal cord in rats, and reported improvement of motor function at the microscopic level associated with cooling \[[@B30]\]. Others reported improvements in functional outcome in various animal models associated with cooling \[[@B30]-[@B32]\]. In an animal study of spinal cord ischemia, hypothermia increased the duration of ischemia required to produce neurological deficits \[[@B31]\].

Moderate hypothermia has also shown potential benefits in invasive procedures including aortic clamp cross-clamping during thoracic surgery \[[@B33],[@B34]\]. This can be regarded as indirect evidence that hypothermia could protect the spinal cord from ischemic injury, although the mechanisms in traumatic injury may be different from surgical trauma and ischemia.

Fever is a common complication in patients with spinal cord injury \[[@B35]-[@B37]\]. Of the identifiable etiologies the most common cause is infection (especially pneumonia and urinary tract infections). However, fever of unknown origin is the most frequent diagnosis, occurring in 66% of patients. It should be realized that patients with spinal cord injury have a high incidence of thermoregulatory problems, which can contribute to the high incidence of FUO \[[@B38],[@B39]\].

Of note, Yu and colleagues demonstrated in an experimental study in rats that post-traumatic hyperthermia in thoracic spinal cord injury worsened behavioral and histopathological damage compared with normothermia, and was associated with an increase of overall contusion volume by increasing the vulnerability of both gray and white matter structures compared with normothermia \[[@B40]\].

Role of moderate hypothermia in the clinical scenario of patients with spinal cord injury
-----------------------------------------------------------------------------------------

Early clinical studies with irrigation to induce local hypothermia produced conflicting results \[[@B41]\]. However, the advent of more reliable cooling devices that can better maintain body temperature within a predetermined range have improved our ability to deliver targeted therapy.

Hypothermia has been used to protect the spinal cord and prevent paraplegia during high aortic cross surgery. In one study with long-term follow-up, the incidence of spinal cord injury in patients undergoing high-risk thoracoabdominal aneurysm repair under hypothermia over a 10-year period the risk of SCI was 18% in hypothermic patients compared with 29% in historical controls (*P*\<0.01) \[[@B29],[@B33]\].

Interest in hypothermia for spinal cord injury received a boost when in 2007 a high-profile case was reported. An NFL player suffered a complete AIS A cervical spine injury, and was treated immediately on the football field with moderate hypothermia. This individual had a much better than expected outcome and this led to a spate of publications on the potential use of hypothermia for spinal cord injury \[[@B40],[@B42]-[@B44]\]. Of course, such anecdotal evidence cannot prove the benefit of any therapy, and professional organizations such as the American Association of neurological surgeons, Neurological and Spine Surgery Joint Sections and Joint Section of Trauma concluded that there was currently not enough evidence available to recommend or discourage the practice of therapeutic hypothermia as a treatment for spinal cord injury \[[@B42],[@B45]-[@B47]\].

In 2009 Levi and colleagues successfully tested the safety and feasibility of systemic hypothermia induction in spinal cord injury with an endovascular cooling device \[[@B48]\]. The authors treated 14 patients with AIS A spinal cord injury with moderate hypothermia. At a median follow-up of 1 year they found an improved conversion rate: in 6/14 cooled patients there was an improvement of the neurological examination (three patients improved to AIS B, two patients improved to AIS C and one patient improved to AIS D). This represents an improvement rate of 42.8%, higher than the 12.5 to 20% found in various other studies where patients had not been treated with hypothermia \[[@B49],[@B50]\]. Complications associated with cooling were mostly respiratory issues (atelectasis and pneumonia) but these rates were similar in the other studies where cooling had not been used. Adverse events such as coagulopathy, deep venous thrombosis and pulmonary embolism were not reported in the patients treated with hypothermia. This is the first investigation on the safety systemic cooling in acute spinal cord injury \[[@B48],[@B51]\].

To determine efficacy will require randomized controlled clinical studies. Currently there are plans to organize such a trial, which will involve 17 centers to determine whether moderate hypothermia improves outcome in a larger population of patients with acute spinal cord injury. Details can be found at online: <http://www.miamiproject.org>. The protocol calls for induction of hypothermia within 6 hours of injury, to be maintained by endovascular cooling, where they will evaluate the safety of different durations of hypothermia, outcomes and risks \[[@B47]\].

Fever in patients with spinal cord injury, if not controlled promptly, may lead to increased morbidity and mortality because of hyperthermic damage to cells. Therefore controlling fever is an important goal of care in these patients. Preliminary data suggest that endovascular cooling can be used effectively for this purpose \[[@B52],[@B53]\].

There are no proven treatments with high grades of scientific evidence for the devastating consequences of spinal cord injury. In Panama, selected patients with ASIA A lesions are treated with therapeutic cooling for a period of 24 to 48 hours. This can be done in either mechanically ventilated or nonventilated patients. Other aspects of treatment include keeping adequate medullar perfusion pressure, normothermia throughout their ICU stay (accomplished by pharmacological interventions, mechanical cooling either with a surface cooling or endovascular device), early enteral immunonutrition, and various tests such as somatosensory evoked potentials.

Conclusion
==========

So far there are no proven therapeutic interventions that improve outcome in severe spinal cord injury. Hypothermia appears to be a promising treatment in this population, and needs to be studied in prospective clinical trials. Fever control should be a goal of care in these patients.
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